orexin antagonist medication development treatment binge eating disorder previously development treatment anxiety orally active smallmolecule compound elimination halflife hours acts selective orexin receptor antagonist may drug phase clinical trials binge eating following negative efficacy results phase trial binge eating disorder idorsia developer signaled may would pursue development drug drug article relating nervous system stub help wikipedia expanding